Trial · NCT01170117
Adverse events16
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 16 of 16
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Mild undulating movement in his posterior tongue on the Abnormal Involuntary Movement Scale | Musculoskeletal and connective tissue disorders | Placebo | 0 | 77 | 0 |
| other | Mild undulating movement in his posterior tongue on the Abnormal Involuntary Movement Scale | Musculoskeletal and connective tissue disorders | Olanzapine | 1 | 75 | 1 |
| other | Rash | Skin and subcutaneous tissue disorders | Placebo | 0 | 77 | 0 |
| other | Rash | Skin and subcutaneous tissue disorders | Olanzapine | 1 | 75 | 1 |
| serious | Patient hospitalized in eating disorder center to pursue higher level of care. | Psychiatric disorders | Placebo | 7 | 77 | 7 |
| serious | Patient hospitalized in eating disorder center to pursue higher level of care. | Psychiatric disorders | Olanzapine | 11 | 75 | 11 |
| serious | Overdose | Injury, poisoning and procedural complications | Placebo | 0 | 77 | 0 |
| serious | Overdose | Injury, poisoning and procedural complications | Olanzapine | 2 | 75 | 2 |
| serious | Abnormal EKG | Cardiac disorders | Placebo | 1 | 77 | 1 |
| serious | Abnormal EKG | Cardiac disorders | Olanzapine | 1 | 75 | 1 |
| serious | Physical injury | Injury, poisoning and procedural complications | Placebo | 3 | 77 | 3 |
| serious | Physical injury | Injury, poisoning and procedural complications | Olanzapine | 2 | 75 | 2 |
| serious | Malignant mass | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 77 | 1 |
| serious | Malignant mass | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Olanzapine | 0 | 75 | 0 |
| serious | Body spasm | Psychiatric disorders | Placebo | 1 | 77 | 1 |
| serious | Body spasm | Psychiatric disorders | Olanzapine | 0 | 75 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01170117/events